When can I start Depo-Provera (medroxyprogesterone acetate) after taking oral contraceptive pills (OCPs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

You can start Depo-Provera (medroxyprogesterone acetate) injections immediately after taking your last active oral contraceptive pill, with no gap needed between methods, as long as the provider is reasonably certain that the patient is not pregnant. This is based on the most recent guidelines from the U.S. Selected Practice Recommendations for Contraceptive Use, 2024 1.

Key Considerations

  • The provider should be reasonably certain that the patient is not pregnant before starting Depo-Provera.
  • If started more than 7 days after the last menstrual period, the patient should abstain from sexual intercourse or use barrier methods (e.g., condoms) for 7 days.
  • No examination or test is needed before initiation of Depo-Provera, according to the guidelines 1.

Transitioning from Oral Contraceptives

  • Simply schedule your first Depo-Provera injection within 7 days of taking your last active pill to ensure continuous contraceptive coverage without requiring backup contraception.
  • If you're switching from combination OCPs, the estrogen and progestin in your pills will continue providing protection while the Depo-Provera begins working.
  • Depo-Provera is a progestin-only injectable contraceptive given as a 150 mg intramuscular injection every 12-13 weeks (3 months).

Backup Contraception

  • If you delay starting Depo-Provera beyond 7 days after your last active pill, you should use backup contraception (like condoms) for 7 days after the injection.
  • This recommendation ensures you maintain contraceptive protection during the transition between methods, as Depo-Provera takes approximately 7 days to become fully effective when not started during your menstrual period, as indicated in the guidelines 1.

From the FDA Drug Label

To ensure the patient is not pregnant at the time of the first injection, the first injection MUST be given ONLY during the first 5 days of a normal menstrual period; The FDA drug label does not answer the question.

From the Research

Switching from Oral Contraceptive Pills to Depo-Provera

To switch from oral contraceptive pills (OCPs) to Depo-Provera (medroxyprogesterone acetate), it is essential to consider the timing and potential interactions between the two methods.

  • The studies 2, 3, 4, 5, 6 do not provide specific guidance on when to start Depo-Provera after taking OCPs.
  • However, it is generally recommended to start Depo-Provera when the next menstrual period is due, or within 5 days of taking the last active OCP pill 3.
  • Women should be aware that switching from OCPs to Depo-Provera may cause changes in menstrual bleeding patterns, which can be a common side effect of progestin-only contraceptives 4.
  • Clinicians should provide adequate counseling and information to women considering switching from OCPs to Depo-Provera, including potential effects on weight, mood, and bone mineral density 3.

Important Considerations

  • Depo-Provera is a highly effective, long-acting contraceptive method that can be used by most women in most circumstances 4.
  • The effectiveness of Depo-Provera is not affected by the timing of the switch from OCPs, but women should be aware of the potential for delayed return of fertility after stopping Depo-Provera 4.
  • Women with premenstrual dysphoric disorder (PMDD) should be cautious when switching to Depo-Provera, as progestin-only methods may negatively affect mood symptoms 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Considerations for the use of progestin-only contraceptives.

Journal of the American Academy of Nurse Practitioners, 2010

Research

Progestin-only contraception: injectables and implants.

Best practice & research. Clinical obstetrics & gynaecology, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.